A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery
Monday, October 12, 2020
10X Triples Down on Spatial Analysis
10X Genomics last week announced the purchase of ReadCoor, a company that unveiled its 3D spatial sequencing instrument back at AGBT, paying $350M to acquire the Cambridge MA company. This follows quickly on the heels of 10X purchasing Swedish in situ sequencing company CartaNA for another $41M. 10X already had the Visium spatial transcriptomics product on the market. So now 10X has three different technologies in the spatial profiling space.
Subscribe to: Posts (Atom)